ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,023Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 288

$444K Total Retail Price of All Prescriptions

Rank: 101 out of 288

451 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 451 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 451 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 9,963 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 546 506 1 2
OMEPRAZOLE 431 390 2 3
LISINOPRIL 396 390 3 4
FUROSEMIDE 358 340 4 5
SIMVASTATIN 354 342 5 1
AMLODIPINE BESYLATE 304 272 6 6
METOPROLOL TARTRATE 255 251 7 8
HYDROCODONE-ACETAMINOPHEN 249 212 S3 8 7
CITALOPRAM HBR 223 209 9 18
PRAVASTATIN SODIUM 216 196 10 21
GLIMEPIRIDE 213 196 11 32
HYDROCHLOROTHIAZIDE 202 202 12 13
LOSARTAN POTASSIUM 200 185 13 16
POTASSIUM CHLORIDE 197 170 14 11
ATENOLOL 190 176 15 10
METOPROLOL SUCCINATE 186 186 16 15
ATORVASTATIN CALCIUM 180 173 17 14
WARFARIN SODIUM 179 176 18 9
POLYETHYLENE GLYCOL 3350 155 135 19 38
METFORMIN HCL 145 140 20 12
ALLOPURINOL 133 112 21 23
TAMSULOSIN HCL 131 117 22 24
GABAPENTIN 122 105 23 17
TRAZODONE HCL 118 89 24 37
ISOSORBIDE MONONITRATE ER 116 116 25 35
ZOLPIDEM TARTRATE 113 93 26 22
LANTUS 103 103 27 31
DONEPEZIL HCL 96 96 28 29
ALENDRONATE SODIUM 95 95 29 20
CARVEDILOL 87 80 30 27
AZITHROMYCIN 85 77 31 49
OXYBUTYNIN CHLORIDE 78 70 32 69
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 64 33 34
PREDNISONE 70 67 34 30
GLIPIZIDE 67 66 35 56
HUMALOG 64 63 36 117
FLUOXETINE HCL 63 51 37 64
RANITIDINE HCL 63 63 37 33
CLOPIDOGREL 62 62 39 47
ADVAIR DISKUS 60 44 40 50
VENLAFAXINE HCL ER 60 60 40 94
LOVASTATIN 59 59 42 46
ENALAPRIL MALEATE 59 59 42 40
PANTOPRAZOLE SODIUM 58 47 44 42
TRIAMTERENE-HCTZ 58 58 44 28
CIPROFLOXACIN HCL 54 50 46 62
INSULIN SYRINGE 52 51 47 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.